| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 11 Dec 25 | CRBP Corbus Pharmaceuticals | Common Stock | Sell | Dispose S | Yes | No | 11.456 | 30,029 | 344.01 k | 2,344,971 |
| 4 Dec 25 | EYPT EyePoint Pharmaceuticals | Common Stock | Sell | Dispose S | Yes | No | 15.704 | 60,000 | 942.24 k | 8,265,000 |
| 30 Sep 25 | MLTX MoonLake Immunotherapeutics | Class A Ordinary Shares | Sell | Dispose S | Yes | No | 6.96 | 5,827 | 40.56 k | 1,994,173 |
| 29 Sep 25 | MLTX MoonLake Immunotherapeutics | Class A Ordinary Shares | Sell | Dispose S | Yes | No | 6.61 | 2,800,000 | 18.51 mm | 2,000,000 |
| 29 Sep 25 | MLTX MoonLake Immunotherapeutics | Class A Ordinary Shares | Sell | Dispose S | Yes | No | 7.58 | 3,390,943 | 25.70 mm | 4,800,000 |
| 29 Sep 25 | MLTX MoonLake Immunotherapeutics | Class A Ordinary Shares | Sell | Dispose S | Yes | No | 8.4 | 232,460 | 1.95 mm | 8,190,943 |
| 29 Sep 25 | MLTX MoonLake Immunotherapeutics | Class A Ordinary Shares | Sell | Dispose S | Yes | No | 9.38 | 70,748 | 663.62 k | 8,423,403 |
| 11 Aug 25 | BBOT BridgeBio Oncology Therapeutics | Common Stock | Grant | Acquire A | Yes | No | 0 | 284,571 | 0.00 | 5,952,356 |
| 11 Aug 25 | BBOT BridgeBio Oncology Therapeutics | Common Stock | Grant | Acquire A | Yes | No | 0 | 1,762,760 | 0.00 | 3,305,470 |
| 11 Aug 25 | BBOT BridgeBio Oncology Therapeutics | Common Stock | Grant | Acquire A | Yes | No | 0 | 1,905,046 | 0.00 | 1,905,046 |